Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.

Item

http://www.wikidata.org/entity/Q38343436

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.

@en

type

Item

label

Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.

@en

prefLabel

Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.

@en

P1476

Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.

@en

P2093

Giovanni Orsolini

http://www.w3.org/2001/XMLSchema#string

Maurizio Rossini

http://www.w3.org/2001/XMLSchema#string

Ombretta Viapiana

http://www.w3.org/2001/XMLSchema#string

Silvano Adami

http://www.w3.org/2001/XMLSchema#string

P2860

Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.

Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007.

A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.

Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study

Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.

Glucocorticoid-induced osteoporosis: an update.

P2888

s12020-014-0506-5

P304

620-627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12020-014-0506-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

davide gatti

P577

2015-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25649760

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis